Kwarlay.com

Navigating the News Maze with Clarity

Medicine

SOTIO Biotech, Biocytogen Ink Research and License Agreement to Develop Next-Generation Antibody-Drug Conjugates

The agreement enables SOTIO to license multiple fully human bispecific antibodies from Biocytogen’s RenLite platform.

FDA Grants Fast Track Designation to Sumitomo Pharma’s Novel Treatment for Patients with Relapsed or Refractory Acute Myeloid Leukemia

DSP-5336 targets the menin and mixed-lineage leukemia protein interaction, crucial in various biological processes, including cell growth and genomic stability.

Congress, Have a More Thoughtful, Bipartisan Pandemic Post-Mortem

Congress and our nation’s public health officials should take the current moment to self-reflect and resolve challenges with public confidence in our public and scientific institutions.

Transforming Patient Care Management: Q&A with Dea Belazi

The AscellaHealth CEO discusses how new technologies are increasing the options in patient care.

Drug Shortages May Have a Compounding Solution: Q&A with Shawn Hodges

The CEO of Revelation Pharma discusses how compounding pharmacies may help solve the ongoing issue with drug shortages.

Amylyx Pharmaceuticals Acquires Phase III-Ready GLP-1 Receptor Agonist Avexitide for Hyperinsulinemic Hypoglycemia from Eiger BioPharmaceuticals

Avexitide has received Breakthrough Therapy Designation by the FDA for post-bariatric hypoglycemia, congenital hyperinsulinism, and more.

Cohort Study Compares Weight Loss Effects of Tirzepatide vs. Semaglutide

JAMA study aims to discover how weight loss differs between patients receiving tirzepatide compared with semaglutide among a clinical population of overweight of obese adults.

The Future of Periodontal Treatment

Advancements in periodontal disease could make way for expansions in the dental space and other medical fields.

Making the Grade: Registries as Sources of Regulatory-Grade RWE

Dr Peter Wahl, MLA, MS, Global Head of Scientific Affairs at CorEvitas, part of Thermo Fisher Scientific, covers key considerations for choosing registries.